Chemikos Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 14-12-2024
- Paid Up Capital ₹ 3.00 M
as on 14-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.16 M
as on 14-12-2024
- Revenue 31.43%
(FY 2020)
- Profit 67.90%
(FY 2020)
- Ebitda 82.83%
(FY 2020)
- Net Worth -15.56%
(FY 2020)
- Total Assets -28.93%
(FY 2020)
About Chemikos Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.16 M.
Raghupathi Anumula and Kavitha Anumula serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC095469
- Company No.
095469
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chemikos Laboratories Private Limited offer?
Chemikos Laboratories Private Limited offers a wide range of products and services, including API Intermediate.
Who are the key members and board of directors at Chemikos Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghupathi Anumula  | Managing Director | 01-Sep-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavitha Anumula | Director | 01-Sep-2014 | Current |
Financial Performance of Chemikos Laboratories.
Chemikos Laboratories Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 31.43% increase. The company also saw a substantial improvement in profitability, with a 67.9% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemikos Laboratories?
In 2020, Chemikos Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Feb 2023 | ₹2.16 M | Open |
How Many Employees Work at Chemikos Laboratories?
Unlock and access historical data on people associated with Chemikos Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemikos Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemikos Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
